Finally, another possible therapeutic approach for ITGA2 would be nanotherapeutics; Guo and collaborators showed that designing ITGA2 antibody-coated nanoparticles containing cytotoxic drugs highly improved drug delivery and cell death in preclinical models of glioblastoma [68]. Here, ITGA2 is linked to glioblastoma.